Medications for Addiction Treatment (MAT) Resources
Description: It is important for healthcare providers to understand the cost of the services ...
Description: With the District of Columbia’s movement to a reimbursement system ...
View materials from this event hosted by Department of Health Care Finance, DBH Training Institute, & Integrated Care DC on May 9, 2023. The in-person workshop was designed for behavioral health providers and other organizations seeking to prepare for the integration of behavioral health into the District’s Medicaid Managed Care Program. Presenters shared information and facilitated exercises to help leadership, clinical and operational staff, and other stakeholders develop the organizational competencies needed to succeed in managed care, including an understanding of managed care principles, how to communicate effectively with managed care partners, and how to effectively demonstrate the value of care through quality measurement and population health.
We often think of the treatment plan as a document to complete. However, it can be a tool to engage and empower the person served in their own recovery process. In this interactive webinar we will learn the core components of the treatment planning process from a person-centered and engagement-focused lens.
There are three main approaches to helping people make a change, directing, following, and a middle-of-the-road approach of guiding. Motivational Interviewing (MI) promotes guiding as an approach to discovering and uncovering an individual’s motivations, concerns, values, and options. This refresher workshop will provide the opportunity to directly practice using MI skills to build discrepancy and move conversations towards enhancing commitment to change.
Understanding, measuring, working to improve quality performance are critical to ensuring that patients have positive outcomes and providers are satisfied—they’re also critical to ensure your practice is meeting its regulatory requirements and maximizing payment opportunities. As the District of Columbia carves in behavioral health care to managed care arrangements and requires more providers to be in value-based care arrangements, it is even more imperative that quality measurement and improvement is understood and infused across your organization—from providers, to leaders, to auxiliary staff.
This two-part series will describe the quality measurement basics and why it matters, and then treatment planning for population health. In Part 1, we will explore why we need to infuse a culture of quality within healthcare organizations, including an understanding of what we value, who we serve, and who we are accountable to. Presenters will emphasize the importance of all staff understanding quality and its impact on our patients, staff and organization. We will review the basics of measurement and key measures in quality focused on integrated care.
In this first workshop, will spend the majority of the time directly practicing foundational OARS skills to evoke interest and commitment to making health behavior changes.
During this webinar, presenters discussed how proactive approaches to value-based care, including the use of VBP models, can improve individual and population health outcomes while enhancing efficiencies and reducing total costs. We also featured AmeriHealth’s new care coordination dashboard focused on helping providers close care gaps and achieve better patient outcomes.
During this webinar, participants will be able to identify the foundations of value-based care and the Health Care Payment Learning & Action Network (HCPLAN or LAN) value-based payment (VBP) framework. The presentation will also include the Department of Health Care Finance’s VBP strategy.
Because many women and persons of childbearing age pregnant with SUD may not readily share information with providers and because pregnancy is a period where the motivation for change is extremely high, positioning providers to identify and care for this population has great potential for establishing a recovery path and changing lives. This webinar will review the risks and effects of SUD among women of childbearing age, pregnant and parenting persons and their affected infants, including screening and treatment considerations, breastfeeding decisions and ideal mechanisms for engagement and support of women and other pregnant persons on their recovery journey. We will also cover the short and long-term effects of SUD exposure on the infants, including non-pharmacologic alternative interventions and follow-up considerations.
During this brief presentation, Kristan McIntosh, LMSW, shares an overview of what a Certified Community Behavioral Health Clinic (CCBHC) is, discusses why it is an important opportunity to build behavioral health system capacity, and talks about some upcoming opportunities to become (or partner with) a CCBHC.
Starting treatment for substance use disorders, like other medical and mental health conditions, requires close follow-up while stabilizing patients, followed by less frequent follow-up after stabilization. The frequency of visits can present an unnecessary barrier to getting care, which can be partially overcome by providing telehealth services. Regulations surrounding Medications for Addiction Treatment have been relaxed compared to years past and now allow for use of telehealth services. We will review the regulations around behavioral health (BH) and substance use disorder (SUD) treatment. Part of the regulatory changes now allow for buprenorphine to be prescribed over telehealth and it is important to become comfortable with the standard of care of home induction of buprenorphine. During this webinar, we will also discuss patient engagement and outcomes for both virtual individual and group treatments. This is the second webinar in a two-part series on Tele-MAT. We will hear from Tele-MAT grantees about their programs, successes and lessons learned during part 1 on January 11, 2021, 12:00pm – 1:00pm ET.
This one-page self-assessment can be utilized before individual or group MAT appointments; this tool aligns with ASAM criteria allowing the provider to plan for the current session and to aid in treatment planning. With a slight modification, this could also be used by persons not on MAT in preparation for individual or group appointments for substance use disorders. Critical questions required for all telehealth appointments are reviewed, such as the address and phone number where the person can be reached today.
The Department of Health Care Finance (DHCF) awarded grants to local organizations to support new telehealth services for residents in Wards 7 and 8 as well as residents of homeless shelters and public housing developments. These projects connect patients to specialists using interactive audio, video, or other new technology. DHCF also awarded grants to local organizations to support telemedicine services among the District’s medication-assisted therapy (MAT) network of providers, including providers authorized (“waivered”) to treat opioid dependency with buprenorphine. During this session, we will hear from the three Tele-MAT grantees about their programs’ successes, challenges and lessons learned. An overview of Tele-MAT will be provided in part 2 of this series on January 25, 2021, 12:00pm - 1:00pm ET.
The front of this handout reviews what providers need to know, do and have a plan for prior to individual or group telehealth sessions. The back of the handout reviews important features of Zoom (TM) for those staff using Zoom (TM) as a platform for delivering telehealth sessions.
This one-page handout is designed for busy outpatient providers who wish to start a patient on buprenorphine but need guidance on what to do before, important things not to forget when starting, how to monitor patients on buprenorphine, what to do if the patient is or is not doing well and duration of treatment.
This one-page handout will help patients understand when they will start buprenorphine, based on the last time they used opioids and their current level of symptoms. It describes how to take buprenorphine in order for it to help with cravings and withdrawal symptoms, what dose of medication to take when starting and afterwards, and other important information about buprenorphine.
This Clinical Guide provides comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants. The Clinical Guide helps healthcare professionals and patients determine the most clinically appropriate action for a particular situation and informs individualized treatment decisions.
Contingency management is an evidence-based treatment plan for substance use disorder. This type of treatment, a major topic in media and public policy circles, promotes behavior change and reinforces positive behaviors. This short take video discusses contingency management treatment in more detail and how to increase its use in more practices.
This toolkit was designed to help community providers care for pregnant and parenting people who use drugs in a holistic manner. The kit includes information about stigma reduction, trauma-informed care, and legal services. While the guide was developed IN NY, there are engagement and other information that is useful regardless of location.
SAMHSA supported the development of this guide in 2018 to promote evidence-informed care for pregnant and parenting women who have OUD. It includes modules on prenatal care, postnatal care, infant care, and more.
Controlled substances (CS) diversion in health systems can lead to serious patient safety issues, harm to the diverter, and significant liability risk to the organization. Diversion driven by addiction puts patients at risk of harm, including inadequate relief of pain, inaccurate documentation of their care in the medical record, exposure to infectious diseases from contaminated needles and drugs, and impaired healthcare worker (HCW) performance. In addition to patient harm, there are regulatory and legal risks to the organization, including fraudulent billing and liability for resulting damages, and decreased community confidence in the healthcare system. These guidelines provide a detailed and comprehensive framework to support organizations in developing their CS diversion prevention program (CSDPP) in order to protect patients, employees, the organization, and the community-at-large. Ultimately, each organization is responsible for developing a CSDPP that complies with applicable federal and state laws and regulations but also one that applies technology and diligent surveillance to routinely review process compliance and effectiveness, strengthen controls, and seek to proactively prevent diversion.
This change guide is designed to assist primary care clinicians and leaders to integrate care for patients with unhealthy alcohol and/or other drug use into routine medical care. As behavioral health care is increasingly integrated into medical settings, especially primary care, the focus is often on depression and anxiety. Care for alcohol and/or other drugs is often omitted or minimized, likely reflecting: stigma, lack of workforce training/education, and the traditional separation of care for alcohol and other drugs from traditional health care (e.g., primary care, emergency care, and behavioral health, etc.). This guide expands on and updates the widely recognized model of Screening, Brief Intervention, and Referral to Treatment (SBIRT).
Integrated Care DC is managed by the DC Department of Health Care Finance (DHCF) in partnership with the DC Department of Behavioral Health (DBH). This project is supported by the U.S. Department of Health and Human Services (HHS). A total of $3,500,365, or 81 percent, of the project is financed with federal funds, and $810,022, or 19 percent, is funded by non-federal sources. The contents are those of the author(s) and do not necessarily represent the official views of, or an endorsement by, HHS or the U.S. Government.